| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.03 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.03 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.03 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.43 | 0.03 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.03 |